Travere Therapeutics (TVTX) Preferred Shares (2012)

Travere Therapeutics' (TVTX) quarterly Preferred Shares came in at $1.0 in Q4 2012, little changed on a QoQ basis from $1.0 in Q1 2012.

Travere Therapeutics (TVTX) Preferred Shares (2012) Analysis & Trends

Travere Therapeutics (TVTX) has 1 years of Preferred Shares data on file, last reported at $1.0 in Q4 2012.

Quarterly Preferred Shares changed N/A year-over-year to $1.0 in Q4 2012, while the trailing twelve-month figure through Nov 2012 was $1.0 (changed N/A YoY) and the FY2012 annual result came in at $1.0, changed N/A from the prior year.
Preferred Shares held at $1.0 in Q4 2012, from $1.0 in the prior quarter.
In the past five years, Preferred Shares ranged from a high of $1.0 in Q1 2012 to a low of $1.0 in Q1 2012.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Travere Therapeutics	5.85 Bn	5.85 Bn	162.52 Mn	-

Download Data

Date	Value
Nov 30, 2012	1.00
Feb 29, 2012	1.00